Investing.com - Financial Markets Worldwide

eXoZymes Inc (EXOZ)

NASDAQ
Currency in USD
10.09
+0.15(+1.51%)
Closed·
After Hours
9.750.00(0.00%)
·
EXOZ Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
EXOZ is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
9.6310.09
52 wk Range
8.5023.99
Key Statistics
Edit
Prev. Close
9.94
Open
9.63
Day's Range
9.63-10.09
52 wk Range
8.5-23.99
Volume
537
Average Volume (3m)
10.02K
1-Year Change
-
Book Value / Share
1.06
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
EXOZ Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 6
Suffers from weak gross profit margins
Unlock InvestingPro

eXoZymes Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell

eXoZymes Inc Company Profile

eXoZymes, Inc. operates as a development stage biotechnology company. The company focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.

Industry
Biotechnology & Medical Research
Sector
Healthcare
Employees
31
Market
United States

eXoZymes Inc Earnings Call Summary for Q1/2025

  • eXoZymes reported Q1 2025 net loss of $1.86M due to R&D investments; maintains $8.51M cash, sufficient through 2026
  • Launched NCTX subsidiary for innovative health products; exploring non-dilutive funding and partnerships for growth
  • Stock fell 2.31% post-earnings to $12.25; InvestingPro data shows overvaluation with P/B of 10.07, strong 15.58% weekly return
  • CEO emphasized cost-effective NCT production and value capture through spin-out strategy; considering future spin-outs/joint ventures
  • Focus on talent acquisition, potential U.S. biomanufacturing shift; market acceptance and competition remain key challenges
Last Updated: 12/05/2025, 22:58
Read Full Transcript

Compare EXOZ to Peers and Sector

Metrics to compare
EXOZ
Peers
Sector
Relationship
P/E Ratio
−12.6x−3.5x−0.5x
PEG Ratio
0.11−0.060.00
Price/Book
9.5x2.1x2.6x
Price / LTM Sales
-10.2x3.3x
Upside (Analyst Target)
-189.3%43.5%
Fair Value Upside
Unlock1.7%6.3%Unlock

Earnings

Latest Release
May 12, 2025
EPS / Forecast
-0.22 / --
Revenue / Forecast
-- / --
EPS Revisions
a
a
Unlock
Last 90 days

EXOZ Income Statement

People Also Watch

INmune Bio
2.69
INMB
-5.78%
Sarepta
16.75
SRPT
-2.06%
BioNexus Gene Lab
5.7300
BGLC
-13.70%
Clearside Biomedical
0.427
CLSD
+2.79%
Windtree Therapeutics
0.532
WINT
-8.54%

FAQ

What Stock Exchange Does eXoZymes Trade On?

eXoZymes is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for eXoZymes?

The stock symbol for eXoZymes is "EXOZ."

What Is the eXoZymes Market Cap?

As of today, eXoZymes market cap is 83.18M.

What Is eXoZymes's Earnings Per Share (TTM)?

The eXoZymes EPS (TTM) is -0.95.

From a Technical Analysis Perspective, Is EXOZ a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has eXoZymes Stock Split?

eXoZymes has split 0 times.

How Many Employees Does eXoZymes Have?

eXoZymes has 31 employees.

What is the current trading status of eXoZymes (EXOZ)?

As of 05 Aug 2025, eXoZymes (EXOZ) is trading at a price of 10.09, with a previous close of 9.94. The stock has fluctuated within a day range of 9.63 to 10.09, while its 52-week range spans from 8.50 to 23.99.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.